• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,968.06 -520.90
( -0.68%)
Global Indices
Nasdaq
50,600.70 294.03
(0.58%)
Dow Jones
7,494.47 27.75
(0.37%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,466.26 22.79
(0.22%)
Forex
USD-INR
95.61 -0.67
(-0.70%)
EUR-INR
110.97 -0.85
(-0.76%)
GBP-INR
128.43 -0.86
(-0.66%)
JPY-INR
0.60 0.00
(-0.79%)

EQUITY - MARKET SCREENER

Amanta Healthcare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
544502
INE084K01015
56.7120864
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AMANTA
31.37
515.27
EPS(TTM)
Face Value()
Div & Yield %
4.23
10
0
 

Cyient Semiconductors ties up equity investment of Rs 100 cr from Edelweiss
May 25,2026

Cyient Semiconductors today announced a strategic financing transaction with funds managed by EAAA India Alternatives (Edelweiss) and affiliated co-investors. The transaction includes an equity investment of approximately USD 10 Mn (Rs 100 crore) at a post-money equity valuation of USD ~500 Mn (Rs 4600 crore), alongside structured debt capital, enabling the company to strengthen its capital structure and support the continued scale-up of its global semiconductor business. The transaction is subject to definitive agreements and customary closing conditions.

The equity investment is alongside a USD 20 Mn in structured debt designed to support long-duration growth.

The combined ~ USD 30 Mn will be deployed across three strategic priorities: advancing the company's product R&D roadmap across custom power semiconductors and custom ASSP's; building in-house semiconductor validation and testing infrastructure in India to strengthen development and qualification capabilities; and supporting working capital requirements as Cyient Semiconductors scales larger, longer-cycle global customer programs.